Aseptic process simulation (APS) is a mandatory requirement from EU-GMP Annex 1, PIC/S and the FDA.
Proof that an aseptic pharmaceutical manufacturing process (including personnel, facilities, materials, and procedures) produces reproducibly contamination-free products and is robust against interference and intervention is provided by the APS, also called media fill.
The approach for a modern GMP-compliant APS is risk-based and includes a complete process simulation.
If the regular APS risk assessment is thoroughly done as part of the process risk analysis, then APS risks can be easily traced.
To meet the compliance requirements of this risk assessment, an APS plan and report and a successful (contamination-free) execution of the APS are expected.
For the execution of APS, a sufficient scope (process steps, batch size, container/closure combinations) plays a key role. In a simulated production process suitable worst-case scenarios for interventions such as interruptions, needle changes, manual transfers and exposure times, complex operations, critical openings, or connections must be considered.
Do you need support in planning and implementing an APS?
Valicare offers a comprehensive APS service package:
- Consulting on a suitable GMP-compliant APS concept
- Creation of a master work instruction (APS SOP) that describes the procedure and provides documentation templates (APS RA, protocol, report) for the CUSTOMER’s processes
- Process risk analysis (if required) with implemented traceability of risks related to aseptic procedures and conditions
- APS-specific risk assessment (APS RA) to define the scope (e.g., process steps, batch size, container/closure combinations) and identify worst case scenarios (e.g., longest exposure times, most complex interventions, most critical openings/connections) and establish acceptance criteria, Alert/action levels, and escalation paths
- Preparation of a detailed APS protocol, which, for example, describes a production-equivalent situation, selection of operators, worst-case interventions, process steps to be conducted during simulation, monitoring data to be recorded in parallel and so on
- Training of staff in the APS procedure and execution
- Control of the operation and analysis (if necessary), including selection, preparation, or purchase of the medium, conducting a growth promotion test, conducting the growth test procedure and collecting the results, and microbiological identification of positive samples.
- Preparation of a detailed APS report to compare the results with the acceptance criteria, documentation of deviations, analysis of the root causes and corrective measures, clear final statement on the success or failure of the APS procedure, requirements for requalification
Are you planning an APS?